novo nordisk semaglutide alzheimer trial evoke said Monday that an older oral version of its diabetes treatment, semaglutide, failed to meet its main goal in Novo Nordisk's Alzheimer's trial a
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30






























